Rehabilitation

Global Exoskeleton Market Analysis/Research Report 2023-2035: Trexo Robotics Partners with Keystone Education Group to Bring Robotic Gait Trainer to Children with Autism - ResearchAndMarkets.com

Retrieved on: 
Monday, March 11, 2024
Robotics, Medical Devices, Health, Consumer, Technology, Children, Geography, United States Census Bureau, ROI, Rehabilitation, Development, Growth, Entrepreneurship, Form, Ageing, Artificial intelligence, Deep learning, Marketing, Accident, CDC, Cloud computing, USCB, Disability, Spectrum, Management

The "Global Exoskeleton Market 2023-2035 by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Exoskeleton Market 2023-2035 by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users and Geography" report has been added to ResearchAndMarkets.com's offering.
  • Through an in-depth examination of historical market data within the industry, we have sought to gain a profound understanding of the evolutionary market trends.
  • Consequently, nearly 40% of the global market for exoskeletons is anticipated to be captured by exoskeleton companies based in North America, in 2035.
  • Further, in June 2023, Trexo Robotics entered into a commercialization agreement with Keystone Education Group to use their Trexo Robotic Gait Trainer exoskeleton for children with autism spectrum disorder.

The Super Patch Company Assembles Industry-Leading Advisory Board to Advance Wellness Technology

Retrieved on: 
Thursday, April 4, 2024
Research, Milwaukee Bucks, NASM, Chicago Bulls, Therapy, FACN, Patient, Insomnia, Sleep, Gut Check, CFS, American Academy, University, Doctor of Philosophy, Overalls, Quality of life, Physical therapy, MLB, Microbiology, VTT, Sports medicine, National academy, Fatigue, Family, PGA Tour, Rehabilitation, Pharmaceutical industry

TORONTO, April 4, 2024 /PRNewswire-PRWeb/ -- The Super Patch Company has announced the formation of a prestigious advisory board composed of renowned medical doctors, scientists, and physical therapists. This board will guide the company's ongoing innovation and lend further credibility to their science-backed approach to general wellness.

Key Points: 
  • The Super Patch Company takes a giant leap forward with a newly formed advisory board featuring top doctors and scientists.
  • TORONTO, April 4, 2024 /PRNewswire-PRWeb/ -- The Super Patch Company has announced the formation of a prestigious advisory board composed of renowned medical doctors, scientists, and physical therapists.
  • "We are thrilled to have assembled such an esteemed group of experts from diverse fields," said Jay Dhaliwal, CEO of The Super Patch Company.
  • Together, they form a powerful team ensuring The Super Patch Company remains at the forefront of drug-free wellness solutions.

REGENATIVE LABS' LATEST PUBLISHED STUDY DEMONSTRATES THE SAFETY AND EFFICACY OF WHARTON'S JELLY CONNECTIVE TISSUE ALLOGRAFT FOR ROTATOR CUFF TEARS

Retrieved on: 
Thursday, April 4, 2024
Knee, MDPI, Stiffness, Shoulder, Safety, Hip, Wharton's jelly, Rotator cuff, Patient, Research, Rehabilitation, Quality of life, Manager, Efficacy, WOMAC, Regenerative medicine, Quality, Literature, Spine, Orthopedic surgery, Pain, Calendar, Physician, Injury, WJ, Medicine, Dentistry

PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.

Key Points: 
  • PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.
  • Patients in need of rotator cuff repairs often seek minimally invasive options, making Wharton's Jelly a promising alternative for musculoskeletal defects.
  • Utilizing the structural connective tissue allografts has allowed many patients to avoid surgery altogether and significantly improve their quality of life."
  • The study titled "Safety and Efficacy of Wharton's Jelly Connective Tissue Allograft for Rotator Cuff Tears," was published by MDPI and can be accessed in its entirety here.

Encompass Health announces preliminary plans to build a 50-bed inpatient rehabilitation hospital in San Antonio

Retrieved on: 
Wednesday, April 3, 2024
EHC, Encompass Health, Amputation, Patient, Hospital, Quality of life, Stroke, Brain, Tetraplegia, DSM-IV codes, Pharmacy, Injury, Nursing, Physician, Rehabilitation

BIRMINGHAM, Ala., April 3, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in San Antonio.

Key Points: 
  • BIRMINGHAM, Ala., April 3, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in San Antonio.
  • The hospital, located in Westover Hills, will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions.
  • In addition to 24-hour nursing care, the hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life.
  • "We are excited to bring inpatient rehabilitation services to the Westover Hills community," said Frank Brown, president of Encompass Health's Southwest region.

American Battery Technology Company Awarded $20 Million Tax Credit through Competitive US DOE Process to Advance its Critical Minerals Battery Recycling Facility

Retrieved on: 
Wednesday, April 3, 2024
Temperature, Employment, Government, American Battery Technology Company, TRIC, Recycling, Acceleration, Reno 1868 FC, Rehabilitation, Public expenditure, University, Mineral, Investment, ABTC, Workforce, DOE, Economic development, ABAT, Lithium

RENO, Nev., April 3, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, was selected for an approximately $20 million award through the Qualifying Advanced Energy Project Credits program (48C). This award was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the U.S. Department of Energy (DOE), which evaluated the feasibility of applicant facilities to advance America's buildout of globally competitive critical material recycling, processing, and refining infrastructure.

Key Points: 
  • RENO, Nev., April 3, 2024 /PRNewswire/ -- American Battery Technology Company (ABTC) (NASDAQ: ABAT), an integrated critical battery materials company that is commercializing its technologies for both primary battery minerals manufacturing and secondary minerals lithium-ion battery recycling, was selected for an approximately $20 million award through the Qualifying Advanced Energy Project Credits program (48C) .
  • These ABTC recycling technologies have won several competitive corporate awards and government grants and are fundamentally different than conventional methods of battery recycling, which generally utilize either high temperature smelting operations or non-strategic shredding systems.
  • Combined with ABTC's previously awarded U.S. DOE grants totaling over $70 million, these funds support investment in the company's battery recycling and primary battery metals commercialization efforts to buildout a domestically-sourced battery metals circular supply chain.
  • These efforts simultaneously aim to foster a sustainable and equitable workforce through partnerships that can propel the new energy transition.

New, Fast-Acting, Conservative Treatment Reverses Scoliosis

Retrieved on: 
Wednesday, April 3, 2024
Spine, MD, Patient, Interview, Yoga, Clinical trial, Rehabilitation, Scoliosis, Nursing

A new clinical trial* demonstrates the efficacy of a unique, non-surgical treatment that quickly reduces curves that can become disabling.

Key Points: 
  • A new clinical trial* demonstrates the efficacy of a unique, non-surgical treatment that quickly reduces curves that can become disabling.
  • Lengthy, uncomfortable bracing and major spinal surgery (36,000 operations annually) can almost always be avoided with this new promising, anatomically-based, non-surgical approach that is a budding trend.
  • Together, this physical maneuver plus botulinum toxin works significantly more effectively than the yoga-like maneuver alone to reverse scoliosis.
  • This new, successful muscle-balancing technique, offers hope to those who are handicapped by scoliosis.

Kessler Foundation Ranks Among Best Nonprofits to Work For in the U.S.

Retrieved on: 
Tuesday, April 2, 2024
Workforce, Rehabilitation, Disability, The NonProfit Times, Employment, Workplace, Kessler Foundation, Research, Philosophy

EAST HANOVER, N.J., April 2, 2024 /PRNewswire/ -- Kessler Foundation, a major nonprofit organization in the field of disability, has placed among the Best Nonprofits to Work For in 2024, a yearly award recognizing the top 50 nonprofits across the U.S.

Key Points: 
  • EAST HANOVER, N.J., April 2, 2024 /PRNewswire/ -- Kessler Foundation, a major nonprofit organization in the field of disability, has placed among the Best Nonprofits to Work For in 2024, a yearly award recognizing the top 50 nonprofits across the U.S.
  • Kessler Foundation, a 501c3 non-profit public charity, is a premier medical research organization with two locations in New Jersey.
  • Nonprofits from across the U.S. entered the two-part survey process to determine the Best Nonprofits to Work For.
  • Kessler Foundation ranked number 16 out of 24 in the medium category (50-249 employees) and number 32 overall.

Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award

Retrieved on: 
Tuesday, April 2, 2024
Pain management, HR, Zynex, Organization, Research, Workplace, Growth, Sale, Rehabilitation, Nursing

ENGLEWOOD, Colo., April 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY.

Key Points: 
  • ENGLEWOOD, Colo., April 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it is a recipient of the prestigious 2024 Top Workplaces USA award, featured in USA TODAY.
  • "Being recognized as a 2024 Top Workplace is a testament to the dedication and passion of our team.
  • Of the more than 42,000 invited organizations, Zynex secured the award based solely on an employee engagement survey administered by Energage, the HR technology and research firm behind the Top Workplaces program.
  • Eric Rubino, Energage CEO, commented, "The Top Workplaces award is a badge of honor and something companies should be very proud to showcase.

Pelvital Announces Advisory Board, Fueling its Mission to Transform the Standard of Care for Urinary Incontinence

Retrieved on: 
Tuesday, April 2, 2024
University, Obstructive sleep apnea, Patient, Pelvic pain, Vocational education, Urodynamic testing, Engineering, Gender, Champaign–Urbana metropolitan area, Pelvic organ prolapse, Carlson School of Management, UnitedHealth Group, Incontinence, Woman, Safety, Strategic communication, Organization, Biomedical engineering, Advisory board, Neurology, Female, Sport, Associate, Research, MD, UIT, Tetraplegia, Urinary incontinence, Biology, Book, FDA, Medtech, Health, Visibility, Growth, Computational biology, Arizent, Mechanical engineering, Physiology, M Health Fairview, Doctor of Philosophy, Integrative Biology, Faculty, Urogynecology, Human, MBA, News, Government, Rehabilitation, Nursing

EAGAN, Minn., April 2, 2024 /PRNewswire-PRWeb/ -- Pelvital, the women's health MedTech company on a mission to transform the standard of care for urinary incontinence, is proud to announce the formation of its formal scientific and business advisory board. This dynamic team of industry leaders and experts will play a pivotal role in supporting the strategic direction and growth of the organization in its ongoing efforts to expand its reach with clinicians, patients, and payors seeking an effective, accessible, conservative treatment option.

Key Points: 
  • EAGAN, Minn., April 2, 2024 /PRNewswire-PRWeb/ -- Pelvital, the women's health MedTech company on a mission to transform the standard of care for urinary incontinence, is proud to announce the formation of its formal scientific and business advisory board.
  • The seven-person advisory board assembles a wealth of experience and expertise with each member having a proven track record of excellence.
  • Dr. Alpert has taught for many years in entrepreneur programs at U.S. and overseas universities, mentoring students and faculty working in the healthcare industry.
  • Their collective knowledge and experience will be instrumental in guiding Pelvital as we embark on an exciting phase of growth and innovation."

China Medical University Hospital Develops "AISIA" to Diagnose Acute Ischemic Stroke in 90 Seconds to Assist Doctors in Making Medical Decisions

Retrieved on: 
Tuesday, April 2, 2024
Diagnosis, Control, Stroke, Blood pressure, Speech, Brain, Pneumonia, Brain ischemia, Kidney, NCCT, Physician, Paralysis, Risk, External carotid artery, Patient, Contrast-induced nephropathy, Cerebrovascular disease, Mortality, Long-term care, Death, Judgement, Deep learning, Nausea, Atherosclerosis, Bleeding, Heart, Neurology, Agent handling, Ministry, Shadow, CTP, Vomiting, Artificial intelligence, Rehabilitation, Dysarthria

The models analyze NCCT and CTP images to detect acute ischemic stroke, as well as to identify the ischemic core and penumbra.

Key Points: 
  • The models analyze NCCT and CTP images to detect acute ischemic stroke, as well as to identify the ischemic core and penumbra.
  • This assist physicians in making decision of acute ischemic stroke management.
  • This system can determine the presence of acute ischemic stroke in approximately 90 seconds.
  • In this way, the facilitated AISIA platform means a lot for ischemic stroke patients and medical experts as well.